Status:

NOT_YET_RECRUITING

Resiliency Intervention for Patients With ALS and Their Care-Partners

Lead Sponsor:

Massachusetts General Hospital

Conditions:

Amyotrophic Lateral Sclerosis (ALS)

Emotional Distress

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to pilot a resiliency and coping intervention for persons recently diagnosed with Amyotrophic Lateral Sclerosis (ALS) and their primary informal caregivers. The data inves...

Detailed Description

The goal of this study to refine our proposed intervention Resilient Together ALS (RT-ALS) through an open pilot. The investigators will deliver an open pilot of the intervention (N= up to10 dyads; up...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for patient with ALS:
  • recent (within \~2 months) of first appointment at Healey Center for diagnosis of ALS documented in Epic (based on recommendations from neurologists)
  • ability to understand the study and research protocol as determined by a standardized teach-back method of assessment
  • ability to communicate by writing, speaking, or assistive communication device
  • Inclusion Criteria for dyad:
  • English speaking adults
  • dyad lives together
  • at least one partner endorses clinically significant emotional distress during screening (\>7 on either subscale of the HADS)
  • Exclusion Criteria:
  • patient with ALS with comorbid terminal diagnosis or severe mental health disorder that limits ability to participate (by self-report, as determined by our clinical team);
  • cognitive disorder that limits ability to participate (per neurologist)
  • inability or unwillingness to use live video technology (will teach any dyads who have low technology literacy how to use live video technology)

Exclusion

    Key Trial Info

    Start Date :

    May 13 2026

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    February 28 2027

    Estimated Enrollment :

    20 Patients enrolled

    Trial Details

    Trial ID

    NCT06968468

    Start Date

    May 13 2026

    End Date

    February 28 2027

    Last Update

    November 17 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Massachusetts General Hospital

    Boston, Massachusetts, United States, 02114

    Resiliency Intervention for Patients With ALS and Their Care-Partners | DecenTrialz